490 related articles for article (PubMed ID: 29504398)
1. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
[TBL] [Abstract][Full Text] [Related]
2. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Oral Delivery of Protein Drugs Using Zwitterion-Functionalized Nanoparticles to Overcome both the Diffusion and Absorption Barriers.
Shan W; Zhu X; Tao W; Cui Y; Liu M; Wu L; Li L; Zheng Y; Huang Y
ACS Appl Mater Interfaces; 2016 Sep; 8(38):25444-53. PubMed ID: 27588330
[TBL] [Abstract][Full Text] [Related]
4. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
5. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
[TBL] [Abstract][Full Text] [Related]
6. Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec).
Zhu S; Chen S; Gao Y; Guo F; Li F; Xie B; Zhou J; Zhong H
Drug Deliv; 2016 Jul; 23(6):1980-91. PubMed ID: 26181841
[TBL] [Abstract][Full Text] [Related]
7. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
[TBL] [Abstract][Full Text] [Related]
8. Overcoming Multiple Absorption Barrier for Insulin Oral Delivery Using Multifunctional Nanoparticles Based on Chitosan Derivatives and Hyaluronic Acid.
Chen Z; Han S; Yang X; Xu L; Qi H; Hao G; Cao J; Liang Y; Ma Q; Zhang G; Sun Y
Int J Nanomedicine; 2020; 15():4877-4898. PubMed ID: 32753869
[TBL] [Abstract][Full Text] [Related]
9. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J
Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840
[TBL] [Abstract][Full Text] [Related]
10. Enhanced oral absorption of insulin using colon-specific nanoparticles co-modified with amphiphilic chitosan derivatives and cell-penetrating peptides.
Guo F; Ouyang T; Peng T; Zhang X; Xie B; Yang X; Liang D; Zhong H
Biomater Sci; 2019 Mar; 7(4):1493-1506. PubMed ID: 30672923
[TBL] [Abstract][Full Text] [Related]
11. Design and Investigation of Penetrating Mechanism of Octaarginine-Modified Alginate Nanoparticles for Improving Intestinal Insulin Delivery.
Li M; Sun Y; Ma C; Hua Y; Zhang L; Shen J
J Pharm Sci; 2021 Jan; 110(1):268-279. PubMed ID: 32663595
[TBL] [Abstract][Full Text] [Related]
12. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
[TBL] [Abstract][Full Text] [Related]
13. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs.
Wu L; Liu M; Shan W; Zhu X; Li L; Zhang Z; Huang Y
J Control Release; 2017 Sep; 262():273-283. PubMed ID: 28774842
[TBL] [Abstract][Full Text] [Related]
14. [Poly(arginine)8 enhanced intestinal absorption of insulin-loaded nanoparticles].
Liu XL; Zhang WJ; Wei G; Lu WY
Yao Xue Xue Bao; 2012 Apr; 47(4):512-6. PubMed ID: 22799036
[TBL] [Abstract][Full Text] [Related]
15. Zwitterion-functionalized mesoporous silica nanoparticles for enhancing oral delivery of protein drugs by overcoming multiple gastrointestinal barriers.
Gao Y; He Y; Zhang H; Zhang Y; Gao T; Wang JH; Wang S
J Colloid Interface Sci; 2021 Jan; 582(Pt A):364-375. PubMed ID: 32861041
[TBL] [Abstract][Full Text] [Related]
16. Thiolated Nanoparticles Overcome the Mucus Barrier and Epithelial Barrier for Oral Delivery of Insulin.
Zhou S; Deng H; Zhang Y; Wu P; He B; Dai W; Zhang H; Zhang Q; Zhao R; Wang X
Mol Pharm; 2020 Jan; 17(1):239-250. PubMed ID: 31800258
[TBL] [Abstract][Full Text] [Related]
17. Complying with the physiological functions of Golgi apparatus for secretory exocytosis facilitated oral absorption of protein drugs.
Xing L; Zheng Y; Yu Y; Wu R; Liu X; Zhou R; Huang Y
J Mater Chem B; 2021 Feb; 9(6):1707-1718. PubMed ID: 33496710
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.
Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Chu L; Yan X; Zhao M; Zhang X; Mu H; Sun K
Mol Pharm; 2019 Feb; 16(2):518-532. PubMed ID: 30601014
[TBL] [Abstract][Full Text] [Related]
19. PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy.
Niu Z; Samaridou E; Jaumain E; Coëne J; Ullio G; Shrestha N; Garcia J; Durán-Lobato M; Tovar S; Santander-Ortega MJ; Lozano MV; Arroyo-Jimenez MM; Ramos-Membrive R; Peñuelas I; Mabondzo A; Préat V; Teixidó M; Giralt E; Alonso MJ
J Control Release; 2018 Apr; 276():125-139. PubMed ID: 29518466
[TBL] [Abstract][Full Text] [Related]
20. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system.
Czuba E; Diop M; Mura C; Schaschkow A; Langlois A; Bietiger W; Neidl R; Virciglio A; Auberval N; Julien-David D; Maillard E; Frere Y; Marchioni E; Pinget M; Sigrist S
Int J Pharm; 2018 May; 542(1-2):47-55. PubMed ID: 29501738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
